Elevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says

MT Newswires Live2025-04-18

Elevance Health's (ELV) preliminary Q1 earnings, reaffirmed 2025 guidance and indications on expected cost trends helped ease market concerns, Truist said Thursday in a report.

The company expects Q1 adjusted net income of $11.97 per diluted share, topping Truist's estimate of $11.58 and the consensus of $11.32. Elevance Health plans to reaffirm 2025 adjusted net income guidance of $34.15 to $34.85 a share.

Elevance Health indicated "medical cost trends developed in line with expectations" in Q1, including in Medicare Advantage, Truist said.

Truist maintained its buy rating on Elevance Health stock with a $510 price target

Full Q1 results are set for Tuesday.

Elevance Health shares fell 2% in recent Thursday trading.

Price: 426.39, Change: -8.65, Percent Change: -1.99

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2528724213?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-18 02:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2528724213","market":"us","top_or_hot":-1,"title":"Elevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a>'s (ELV) preliminary Q1 earnings, reaffirmed 2025 guidance and indications on expected cost trends helped ease market concerns, Truist said Thursday in a report.</p><p>The company expects Q1 adjusted net income of $11.97 per diluted share, topping Truist's estimate of $11.58 and the consensus of $11.32. Elevance Health plans to reaffirm 2025 adjusted net income guidance of $34.15 to $34.85 a share.</p><p>Elevance Health indicated \"medical cost trends developed in line with expectations\" in Q1, including in Medicare Advantage, Truist said.</p><p>Truist maintained its buy rating on Elevance Health stock with a $510 price target</p><p>Full Q1 results are set for Tuesday.</p><p>Elevance Health shares fell 2% in recent Thursday trading.</p><p>Price: 426.39, Change: -8.65, Percent Change: -1.99</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-18 02:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a>'s (ELV) preliminary Q1 earnings, reaffirmed 2025 guidance and indications on expected cost trends helped ease market concerns, Truist said Thursday in a report.</p><p>The company expects Q1 adjusted net income of $11.97 per diluted share, topping Truist's estimate of $11.58 and the consensus of $11.32. Elevance Health plans to reaffirm 2025 adjusted net income guidance of $34.15 to $34.85 a share.</p><p>Elevance Health indicated \"medical cost trends developed in line with expectations\" in Q1, including in Medicare Advantage, Truist said.</p><p>Truist maintained its buy rating on Elevance Health stock with a $510 price target</p><p>Full Q1 results are set for Tuesday.</p><p>Elevance Health shares fell 2% in recent Thursday trading.</p><p>Price: 426.39, Change: -8.65, Percent Change: -1.99</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2528724213","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2528724213","pubTimestamp":1744913753,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Elevance Health's  preliminary Q1 earnings, reaffirmed 2025 guidance and indications on expected cost trends helped ease market concerns, Truist said Thursday in a report.The company expects Q1 adjusted net income of $11.97 per diluted share, topping Truist's estimate of $11.58 and the consensus of $11.32. Elevance Health plans to reaffirm 2025 adjusted net income guidance of $34.15 to $34.85 a share.Elevance Health indicated \"medical cost trends developed in line with expectations\" in Q1, including in Medicare Advantage, Truist said.Truist maintained its buy rating on Elevance Health stock with a $510 price targetFull Q1 results are set for Tuesday.Elevance Health shares fell 2% in recent Thursday trading.Price: 426.39, Change: -8.65, Percent Change: -1.99","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"Truist表示，Elevance Health第一季度初步收益有助于缓解市场担忧","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"Elevance Health's (ELV) preliminary Q1 earnings, reaffirmed 2025 guidance and indications on expected cost trends helped ease market concerns, Truist said Thursday in a report.The company expects Q1 adjusted net income of $11.97 per diluted share, topping Truist's estimate of $11.58 and the consensus of $11.32. Elevance Health plans to reaffirm 2025 adjusted net income guidance of $34.15 to $34.85 a share.Elevance Health indicated \"medical cost trends developed in line with expectations\" in Q1, including in Medicare Advantage, Truist said.Truist maintained its buy rating on Elevance Health stock with a $510 price targetFull Q1 results are set for Tuesday.Elevance Health shares fell 2% in recent Thursday trading.Price: 426.39, Change: -8.65, Percent Change: -1.99","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2528724213","isCrawlerRequest":true}